Reports
Reports
Sale
The Mexico in-vitro diagnostics market grew a CAGR of 17.1% during the period 2018-2023. Analysis of human samples offers physicians with vital information to properly diagnose, treat, and prevent illnesses. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. In-vitro diagnostics can help identify early warning signs and individual risk factors, generating new openings for prevention and early intervention. Some in-vitro diagnostics range beyond the laboratory, hospital or doctor’s office, enabling patients with chronic illnesses to self-monitor and manage their own conditions. These factors are expected to drive market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In-vitro diagnostic devices (IVDs) are considered medical devices in Mexico; COFEPRIS does not differentiate the regulation between medical devices and in-vitro diagnostic devices. In-vitro diagnostic devices (IVDs) generally comprise reactants, controls, calibrators and equipment or devices with the help of which diagnosis is carried out. It is noteworthy that IVDs could be part of a medical diagnosis equipment and sold with it, but in terms of regulatory treatment, these are considered independent medical devices. For example, a glucometer device is considered medical equipment while the test strips are considered IVDs.
In-vitro diagnostic products are classified as Class I or II, according to diagnosed parameters. In general, the Classification and Grouping Rules lay down that IVDs related to highly infectious or life-threatening illnesses must be considered class II medical devices; the rest are considered class I.
In developing countries, rising levels of income and standards of living are expected to stimulate a new, health-conscious populace seeking quality medical care, and drive the Mexico in-vitro diagnostics market. Key drivers are expected to be growing population, government insurance, patients that are newly insured, and modernized healthcare facilities.
In-vitro diagnostics (IVDs) are assays employed to conduct tests on clinical samples taken from the body, including blood, urine, or tissue. The assays seek to screen for disease, identify a medical condition, observe therapy usage, or prevent disease. Nearly seventy percent of medical decisions are made on the basis of data offered by in-vitro diagnostics (IVDs), thus, these have assumed critical importance in patient care. In recent years, IVDs have gained even more popularity due to their capability of saving lives through early identification of medical conditions. The use of IVDs to determine underlying genetic conditions in addition to diagnostic screening could prevent unnecessary suffering by a patient and decrease the scale of treatment required.
Improved ease-of-use and greater reliability has led to use of IVDs in home settings also. For example, users today easily perform tests to monitor blood glucose levels, determine urinary tract infections, monitor ovulation, and confirm pregnancy. Such tests enable individuals to manage their health and offer quick results to enable further medical action. These advantages are expected to drive the Mexico in-vitro diagnostics market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is segmented into:
By technology, the market is classified into:
By usability, the market is classified into:
By end use, the market is divided into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the Mexico in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Technology |
|
Breakup by Usability |
|
Breakup by End Use |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Mexico
7 Opportunities and Challenges in the Market
8 Latin America In-Vitro Diagnostics Market Overview
8.1 Key Industry Highlights
8.2 Latin America In-Vitro Diagnostics Historical Market (2018-2023)
8.3 Latin America In-Vitro Diagnostics Market Forecast (2024-2032)
8.4 Latin America In-Vitro Diagnostics Market by Country
8.4.1 Brazil
8.4.2 Argentina
8.4.3 Mexico
8.4.4 Others
9 Mexico In-Vitro Diagnostics Market Analysis
9.1 Key Industry Highlights
9.2 Mexico In-Vitro Diagnostics Historical Market (2018-2023)
9.3 Mexico In-Vitro Diagnostics Market Forecast (2024-2032)
9.4 Mexico In-Vitro Diagnostics Market by Product
9.4.1 Reagents
9.4.1.1 Historical Trend (2018-2023)
9.4.1.2 Forecast Trend (2024-2032)
9.4.2 Instruments
9.4.2.1 Historical Trend (2018-2023)
9.4.2.2 Forecast Trend (2024-2032)
9.4.3 Others
9.5 Mexico In-Vitro Diagnostics Market by Technology
9.5.1 Clinical Chemistry
9.5.1.1 Historical Trend (2018-2023)
9.5.1.2 Forecast Trend (2024-2032)
9.5.2 Molecular Diagnostics
9.5.2.1 Historical Trend (2018-2023)
9.5.2.2 Forecast Trend (2024-2032)
9.5.3 Immuno Diagnostics
9.5.3.1 Historical Trend (2018-2023)
9.5.3.2 Forecast Trend (2024-2032)
9.5.4 Haematology
9.5.4.1 Historical Trend (2018-2023)
9.5.4.2 Forecast Trend (2024-2032)
9.5.5 Others
9.6 Mexico In-Vitro Diagnostics Market by Usability
9.6.1 Disposable IVD Devices
9.6.1.1 Historical Trend (2018-2023)
9.6.1.2 Forecast Trend (2024-2032)
9.6.2 Reusable IVD Devices
9.6.2.1 Historical Trend (2018-2023)
9.6.2.2 Forecast Trend (2024-2032)
9.7 Mexico In-Vitro Diagnostics Market by End Use
9.7.1 Diagnostic Laboratories
9.7.1.1 Historical Trend (2018-2023)
9.7.1.2 Forecast Trend (2024-2032)
9.7.2 Hospitals and Clinics
9.7.2.1 Historical Trend (2018-2023)
9.7.2.2 Forecast Trend (2024-2032)
9.7.3 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 F Hoffmann-La Roche Ltd.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Becton, Dickinson and Company
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Bio-Rad Laboratories Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Siemens Healthineer AG
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Abbott Laboratories
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Latin America In-Vitro Diagnostics Market: Key Industry Highlights, 2018 and 2032
2. Mexico In-Vitro Diagnostics Market: Key Industry Highlights, 2018 and 2032
3. Mexico In-Vitro Diagnostics Historical Market: Breakup by Product (USD Million), 2018-2023
4. Mexico In-Vitro Diagnostics Market Forecast: Breakup by Product (USD Million), 2024-2032
5. Mexico In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2018-2023
6. Mexico In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
7. Mexico In-Vitro Diagnostics Historical Market: Breakup by Usability (USD Million), 2018-2023
8. Mexico In-Vitro Diagnostics Market Forecast: Breakup by Usability (USD Million), 2024-2032
9. Mexico In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2018-2023
10. Mexico In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
11. Mexico In-Vitro Diagnostics Market Structure.
The Mexico in-vitro diagnostics market is projected to grow at a CAGR of 17.1% between 2024 and 2032.
The major drivers of the market include the rising levels of income, growing population, government insurance, newly insured patients, and modernised healthcare facilities.
Advancements in technology and demand for quality medical care are the key industry trends propelling the market's growth.
The various products in the market are reagents and instruments, among others.
Based on technology, the market is segmented into clinical chemistry, molecular diagnostics, immuno diagnostics and haematology, among others.
Based on usability, the market is bifurcated into disposable IVD devices and reusable IVD devices.
The end-uses of the market are hospital and clinics and diagnostic laboratories, among others.
The major players in the industry are F Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Siemens Healthineer AG, and Abbott Laboratories, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.